Ola Åberg
Researcher at Department of Medicinal Chemistry; Preclinical PET-MRI Platform
- E-mail:
- ola.aberg@ilk.uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Dag Hammarskjöldsv 14C, 3 tr
751 83 Uppsala
Short presentation
I am working as a researcher/teacher in radiopharmaceutical organic chemistry at the Preclinical PET Platform.
- Radiochemistry with 11C, 18F, 68Ga, 111In, 125I, 177Lu
- Transition metal catalysis
- Bioorthogonal chemistry
- Cancer imaging, neuro imaging
I am also working as IT e-coordinator for Research administration, and Handling of research data.
Biovia Notebook, REDCap, iLab, Doktoranddatabasen, Disputationskalendern, Allvis etc.
I am a part of the Research data support group at UU.
Biography
2012 - Present Uppsala university, Preclinical PET Platform. Researcher, e-coordinator.
2010 - 2012 Imperial College London, UK. Research Associate.
2005- 2009 Uppsala university, Department of Biochemistry and Organic Chemistry. PhD student.

Publications
Selection of publications
-
Toward molecular imaging of the free fatty acid receptor 1
Part of Acta Diabetologica, p. 663-668, 2017
- DOI for Toward molecular imaging of the free fatty acid receptor 1
- Download full text (pdf) of Toward molecular imaging of the free fatty acid receptor 1
-
Part of ChemistryOpen, p. 566-573, 2016
- DOI for Synthesis of C-11-labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [C-11]CO
- Download full text (pdf) of Synthesis of C-11-labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [C-11]CO
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014
-
A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth.
Part of British Journal of Cancer, p. 342-50, 2013
- DOI for A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth.
-
Part of MedChemComm, p. 693-696, 2013
-
Part of Journal of labelled compounds & radiopharmaceuticals, p. 477-483, 2012
-
18F-labelling of a cyclic pentapeptide inhibitor of the chemokine receptor CXCR4
Part of Journal of fluorine chemistry, p. 200-206, 2012
-
Synthesis of substituted [C-11]ureas and [C-11]sulphonylureas by Rh(I)-mediated carbonylation
Part of Journal of labelled compounds & radiopharmaceuticals, p. 38-42, 2011
-
Part of Journal of labelled compounds & radiopharmaceuticals, p. 151-157, 2009
-
Synthesis and Biological Evaluation of [Carboxyl-11C]eprosartan
Part of Journal of labelled compounds & radiopharmaceuticals, p. 295-303, 2009
-
Synthesis of [11C]/[13C]acrylamides by palladium-mediated carbonylation
Part of European Journal of Organic Chemistry, p. 455-461, 2007
Recent publications
-
2023
-
2023
-
Part of Advanced Therapeutics, 2022
- DOI for Heparin-Derived Theranostic Nanoprobes Overcome the Blood-Brain Barrier and Target Glioma in Murine Model
- Download full text (pdf) of Heparin-Derived Theranostic Nanoprobes Overcome the Blood-Brain Barrier and Target Glioma in Murine Model
-
Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
Part of Scientific Reports, 2021
- DOI for Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
- Download full text (pdf) of Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
-
Part of Nuclear Medicine and Biology, p. 54-62, 2021
- DOI for Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1
- Download full text (pdf) of Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1
All publications
Articles in journal
-
Part of Advanced Therapeutics, 2022
- DOI for Heparin-Derived Theranostic Nanoprobes Overcome the Blood-Brain Barrier and Target Glioma in Murine Model
- Download full text (pdf) of Heparin-Derived Theranostic Nanoprobes Overcome the Blood-Brain Barrier and Target Glioma in Murine Model
-
Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
Part of Scientific Reports, 2021
- DOI for Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
- Download full text (pdf) of Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69
-
Part of Nuclear Medicine and Biology, p. 54-62, 2021
- DOI for Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1
- Download full text (pdf) of Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1
-
18F-Radiolabeling and Preliminary Evaluation of a HSP90 ligand
Part of European Journal of Pharmaceutical Sciences, 2021
-
Toward molecular imaging of the free fatty acid receptor 1
Part of Acta Diabetologica, p. 663-668, 2017
- DOI for Toward molecular imaging of the free fatty acid receptor 1
- Download full text (pdf) of Toward molecular imaging of the free fatty acid receptor 1
-
Part of ChemistryOpen, p. 566-573, 2016
- DOI for Synthesis of C-11-labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [C-11]CO
- Download full text (pdf) of Synthesis of C-11-labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [C-11]CO
-
Part of ChemistryOpen, p. 566-573, 2016
- DOI for Synthesis of 11C-labelled Sulfonyl Carbamates via a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols and [11C]CO
- Download full text (pdf) of Synthesis of 11C-labelled Sulfonyl Carbamates via a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols and [11C]CO
-
Part of EJNMMI Research, 2014
- DOI for Strategy to develop a MAO-A-resistant 5-hydroxy-L-[beta-C-11]tryptophan isotopologue based on deuterium kinetic isotope effects
- Download full text (pdf) of Strategy to develop a MAO-A-resistant 5-hydroxy-L-[beta-C-11]tryptophan isotopologue based on deuterium kinetic isotope effects
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2014
-
Part of PLOS ONE, 2013
- DOI for In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging
- Download full text (pdf) of In Vitro and In Vivo Evaluation of a F-18-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging
-
A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth.
Part of British Journal of Cancer, p. 342-50, 2013
- DOI for A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth.
-
Part of MedChemComm, p. 693-696, 2013
-
Part of Journal of labelled compounds & radiopharmaceuticals, 2013
-
(AlF)-F-18-labelling of NOTA-P2-RM26 and its evaluation as a PET ligand for GRPR/BB2
Part of Journal of labelled compounds & radiopharmaceuticals, 2013
-
Part of European Journal of Nuclear Medicine and Molecular Imaging, 2013
-
Part of Journal of labelled compounds & radiopharmaceuticals, p. 679-685, 2013
-
Part of Journal of labelled compounds & radiopharmaceuticals, p. 477-483, 2012
-
18F-labelling of a cyclic pentapeptide inhibitor of the chemokine receptor CXCR4
Part of Journal of fluorine chemistry, p. 200-206, 2012
-
Synthesis of substituted [C-11]ureas and [C-11]sulphonylureas by Rh(I)-mediated carbonylation
Part of Journal of labelled compounds & radiopharmaceuticals, p. 38-42, 2011
-
Synthesis and evaluation of a 11C-labelled angiotensin II AT2 receptor ligand
Part of Journal of labelled compounds & radiopharmaceuticals, p. 616-624, 2010
-
Part of Journal of labelled compounds & radiopharmaceuticals, p. 151-157, 2009
-
Synthesis and Biological Evaluation of [Carboxyl-11C]eprosartan
Part of Journal of labelled compounds & radiopharmaceuticals, p. 295-303, 2009
-
Synthesis of [11C]/[13C]acrylamides by palladium-mediated carbonylation
Part of European Journal of Organic Chemistry, p. 455-461, 2007
Comprehensive doctoral thesis
-
2009
Manuscripts (preprints)
Reports
-
2023
-
2023